Human umbilical cord-derived mesenchymal stem cell therapy (Zhejiang Jinshidai)
人脐带间充质干细胞（浙江金时代）
Report date: 2023/08/18 11:51:14
Base Information
Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Zhejiang Jinshidai)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesZhejiang Jinshidai Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesZhejiang Jinshidai Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A